Development and comparison of three 89Zr-labeled anti-CLDN18.2 antibodies to noninvasively evaluate CLDN18.2 expression in gastric cancer: a preclinical studyGuilan Hu, Li Huo, Chao Fu et al.|European Journal of Nuclear Medicine and Molecular Imaging|2022Cited by 39